AKT1 and diffuse large B-cell lymphoma: Overexpression of miR-155 in diffuse large B-cell lymphoma could down-regulate p85α, resulting in activation of the oncogenic PI3K/AKT signaling pathway, which increases cell proliferation (Figure 3).